VOYA Investment Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,282
Closed -$27.5K 2754
2025
Q1
$27.5K Sell
17,282
-39,735
-70% -$85.7K ﹤0.01% 2602
2024
Q4
$173K Buy
57,017
+7,058
+14% +$23.1K ﹤0.01% 2435
2024
Q3
$184K Buy
49,959
+30,716
+160% +$112K ﹤0.01% 2507
2024
Q2
$78.7K Sell
19,243
-125,380
-87% -$1.4M ﹤0.01% 2728
2024
Q1
$2.28M Sell
144,623
-4,232
-3% -$58.2K ﹤0.01% 1309
2023
Q4
$2.26M Buy
148,855
+38,753
+35% +$565K ﹤0.01% 1330
2023
Q3
$2.21M Buy
110,102
+3,780
+4% +$95.9K ﹤0.01% 1295
2023
Q2
$3M Buy
106,322
+88,558
+499% +$2.12M ﹤0.01% 1196
2023
Q1
$306K Hold
17,764
﹤0.01% 2318
2022
Q4
$358K Hold
17,764
﹤0.01% 2218
2022
Q3
$385K Buy
17,764
+3,452
+24% +$94.4K ﹤0.01% 2193
2022
Q2
$402K Hold
14,312
﹤0.01% 1971
2022
Q1
$660K Buy
14,312
+292
+2% +$15.8K ﹤0.01% 1746
2021
Q4
$1.18M Buy
14,020
+226
+2% +$17.5K ﹤0.01% 1442
2021
Q3
$919K Buy
13,794
+733
+6% +$42.3K ﹤0.01% 1629
2021
Q2
$695K Buy
13,061
+513
+4% +$27.5K ﹤0.01% 1892
2021
Q1
$544K Buy
12,548
+599
+5% +$25.8K ﹤0.01% 1984
2020
Q4
$621K Buy
+11,949
New +$539K ﹤0.01% 1777

Other funds holding ZNTL

VOYA Investment Management's ZNTL Position: Q2 2025 in Review

VOYA Investment Management sold out of Zentalis Pharmaceuticals (ZNTL) in Q2 2025, closing a stake of 17,282 shares — an estimated $27.5K sold.

VOYA Investment Management first reported a position in ZNTL in Q4 2020 and held it in 18 quarters. The position peaked at $3M in Q2 2023. 117 funds tracked by Wall St. Rank hold ZNTL as of Q2 2025.

  • VOYA Investment Management reported no remaining Zentalis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • VOYA Investment Management sold 17,282 Zentalis Pharmaceuticals shares in Q2 2025, an estimated $27.5K.
  • VOYA Investment Management first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 18 quarters.
  • VOYA Investment Management's Zentalis Pharmaceuticals position peaked at $3M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2025.

Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.